Comparison of Different Up-dosing Schedules With Osiris.
Phase of Trial: Phase II
Latest Information Update: 26 Aug 2011
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Allergic rhinitis; Grass pollen hypersensitivity
- Focus Adverse reactions; Therapeutic Use
- Sponsors ALK-Abello
- 26 Aug 2011 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
- 11 Nov 2010 New trial record